和嘉控股(00704.HK)接獲額外復牌指引 續停牌
和嘉控股(00704.HK)公佈,於2月14日接獲聯交所額外復牌指引,要求公司進行獨立內部監控審閱,證明發行人具備足夠內部監控及程序,以遵守上市規則;證明並無針對管理層誠信或對管理營運有重大影響力的任何人士之誠信的合理監管疑慮;及證明公司董事符合擔任上市發行人董事應有的勝任標準,有能力按上市規則履行職務。
聯交所同時修訂復牌指引,要求公司對貸款及或有負債進行適當的調查、評估對業務運營和財務狀況的影響、發佈調查結果並採取適當的補救措施。
應公司要求,股份已自2021年3月29日起暫停買賣,並將繼續暫停直至另行通知。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.